Pelvic Exenteration for Recurrent and Persistent Cervical Cancer.

ABSTRACT:

Background

Pelvic exenteration (PE) for primary and recurrent cervical cancer has resulted in favorable survival outcomes, but there are controversies about specific prognosis factors, and up to now, there have been no published reports from China. This study aimed to share our experiences of PE, which were performed in a single institution.

Methods

From January 2009 to January 2016, 38 patients with recurrent or persistent cervical cancer were included in the study, and they were followed up until January 2017. Epidemiological and clinicopathological characteristics of patients were compared for survival outcomes in univariate and Cox hazard regression analysis.

Results

There were thirty-one and seven patients with recurrent and persistent cervical cancer, respective

SUBMITTER: Li L 

PROVIDER: S-EPMC6032675 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature